AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS
申请人:SignalChem Lifesciences Corporation
公开号:EP3074390A2
公开(公告)日:2016-10-05
COMBINATION THERAPY FOR TREATING BLOOD CANCER
申请人:SIGNALCHEM LIFESCIENCES CORPORATION
公开号:US20220031685A1
公开(公告)日:2022-02-03
Provided herein are combination therapies for treating blood cancer, in particular, acute myeloid leukemia, by concurrently targeting Axl and BCL-2.
[EN] AMINOPYRIDINE DERIVATIVES AS TAM FAMILY KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'AMINOPYRIDINE UTILISÉS COMME INHIBITEURS DE KINASES DE LA FAMILLE TAM
申请人:SIGNALCHEM LIFESCIENCES CORP
公开号:WO2015081257A2
公开(公告)日:2015-06-04
Provided herein are aminopyridine derivatives and pharmaceutical compositions that are useful as TAM family kinase inhibitors.